Study on Long-Term Effects of Radiotherapy for Cancer

Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy

Recruiting Observational Study
Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 120
Sex
Any
Study type
Observational
Participants needed
700 (estimated)
Sponsor
National Cancer Institute (NCI) · NIH
Who this trial is looking for

This trial is looking for people who have received radiation therapy for cancer. Participants will be followed up to collect information about their health and any long-term effects from the treatment.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have received radiation therapy.
  • I am at least 18 years old.
  • I am able to provide informed consent.
  • I have a primary physician in my community.

You may not be able to join if

  • I am currently enrolled in another interventional research study at NIH.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
BACKGROUND * This protocol acknowledges that it is in the interest of the NIH and ROB, as well as our participants, to continue to follow those who have been treated with radiotherapy at ROB and are not otherwise eligible for current active research protocols. * It also provides a mechanism for the correlation and interpretation of disparate data for research into the long term side effects and o…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: ROB investigator deems that it is in the best interests of the participant and the NCI/ROB for the participant to be seen in follow-up in the ROB clinic. Participant is able to provide informed consent. Participant must have a primary physician in the community to whom recor…
Contacts

Rukayat O Salau

(240) 858-3712

rukayat.salau@nih.gov

CONTACT

Kevin A Camphausen, M.D.

(240) 760-6205

camphauk@mail.nih.gov

CONTACT